Hydrochlorothiazide Tablet
Product Images NDC 60760-315

2 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 60760-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrochlorothiazide (Ca6c8d06 Bcfc 4c15 922a A2c52089488f 01)

Hydrochlorothiazide (Ca6c8d06 Bcfc 4c15 922a A2c52089488f 01)
Chemical structure of hydrochlorothiazide showing its molecular formula C7H8ClN3O4S2 and molecular weight 297.74. The image depicts the arrangement of atoms, including chlorine, sulfur, nitrogen, oxygen, and hydrogen, within the hydrochlorothiazide molecule.*
FDA Label Image

315 (Hydrochlorothizaide 25mg 30ct 60760 315 30)

315 (Hydrochlorothizaide 25mg 30ct 60760 315 30)
Label for Hydrochlorothiazide Tablets, USP 25 mg, oral tablet form. The package contains 30 tablets. Manufactured by Unichem Laboratories Ltd, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes storage instructions (20° to 25°C), directions for pharmacists to dispense in a well-closed container, and notes the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.